ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,119.52
0.38%
US Tech 100
17,297.20
0.33%
다우존스 지수
38,363.92
0.32%
Bitcoin
63,205.20
0.33%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Panbela Therapeutics Inc (PBLA)

  7. Panbela Therapeutics Inc (PBLA) 뉴스

PBLA Panbela Therapeutics Inc

1.11
0.00 (0.00%)
최종 업데이트: 09:00:00
15분 지연
기업명 주식 심볼 시장 주식 타입
Panbela Therapeutics Inc PBLA 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.00 0.00% 1.11 09:00:00
개장가 저가 고가 종가 전일 종가
1.11
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
27/04/202405:39EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
26/04/202405:36EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
26/04/202405:35EDGAR2Form 8-K - Current report
25/04/202422:09EDGAR2Form 25-NSE - Notification filed by national security..
22/04/202421:02EDGAR2Form 8-K - Current report
22/04/202421:00GLOBEPanbela Therapeutics Announces Interim Data Analysis for..
19/04/202405:31EDGAR2Form S-1 - General form for registration of securities under..
18/04/202421:00GLOBEPanbela Announces Poster Presentation at American..
17/04/202421:36EDGAR2Form 8-K - Current report
17/04/202413:15EDGAR2Form EFFECT - Notice of Effectiveness
17/04/202406:29GLOBEPanbela Announces Transfer to OTCQB Market
05/04/202405:17EDGAR2Form DEF 14A - Other definitive proxy statements
30/03/202406:24EDGAR2Form S-1 - General form for registration of securities under..
30/03/202406:08EDGAR2Form POS AM - Post-Effective amendments for registration..
27/03/202405:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/03/202405:12EDGAR2Form 8-K - Current report
27/03/202405:10GLOBEPanbela Provides Business Update and Reports Q4 and FY 2024..
26/03/202420:21IHMARKETNEWSU.S. Index Futures on the Rise, Oil Prices Show Stability
26/03/202405:15EDGAR2Form PRE 14A - Other preliminary proxy statements
13/03/202405:15GLOBEPanbela to Host Fourth Quarter and Year End 2023 Earnings..
07/03/202420:01EDGAR2Form 8-K - Current report
15/02/202422:05EDGAR2Form 8-K - Current report
15/02/202422:00GLOBEPanbela Regains Compliance with Nasdaq Listing Standards for..
14/02/202410:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202407:24EDGAR2Form 8-K - Current report
01/02/202421:15EDGAR2Form 8-K - Current report
01/02/202421:00GLOBEPanbela Announces Closing of Approximately $9.0 Million..
31/01/202407:28EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
30/01/202422:15GLOBEAcceptance of Ivospemin (SBP-101) Abstract for Poster..
29/01/202420:21EDGAR2Form 8-K - Current report
29/01/202420:15GLOBEPanbela Announces Pricing of Approximately $9.0 Million..
26/01/202402:22EDGAR2Form S-1/A - General form for registration of securities..
25/01/202422:54EDGAR2Form S-1/A - General form for registration of securities..
25/01/202421:00GLOBEPanbela Exceeds 50% Enrollment for Aspire Trial in..
22/01/202420:08EDGAR2Form S-1/A - General form for registration of securities..
20/01/202407:20EDGAR2Form 8-K - Current report
18/01/202422:15GLOBEPanbela Announces Publication of Clinical Data Titled: Phase..
16/01/202422:00GLOBEPanbela Announces 1-for-20 Reverse Stock Split Effective..
06/01/202406:34EDGAR2Form S-8 - Securities to be offered to employees in employee..
21/12/202323:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
21/12/202323:25EDGAR2Form 8-K - Current report
21/12/202323:15GLOBEPanbela Therapeutics Announces Exercise of Warrants and..
21/12/202320:00EDGAR2Form 8-K - Current report
18/12/202322:15GLOBEPanbela Therapeutics Announces US WorldMeds NDA Approval for..
04/12/202322:00GLOBEPanbela Announces Publication of Abstract Titled: Evaluation..
02/12/202306:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
02/12/202306:15EDGAR2Form 8-K - Current report
29/11/202322:15GLOBEPanbela Announces 2nd Independent Safety Review of the..
25/11/202306:30EDGAR2Form DEF 14A - Other definitive proxy statements
23/11/202307:01EDGAR2Form S-1 - General form for registration of securities under..

최근 히스토리

NASDAQ
PBLA
Panbela Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유